Nasser H. Hanna, MD
Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research
Professor of Medicine
Associate Division Director - Oncology
- Address
-
Indiana Cancer Pavilion, Suite 473
535 Barnhill Dr
RT 473
Indianapolis, IN 46202-5289 - PubMed:
| Year | Degree | Institution |
|---|---|---|
| 2000 | Fellowship | Indiana University Medical Center, Indianapolis, IN |
| 1998 | Residency | University of Iowa, Iowa City, IA |
| 1995 | MD | University of Missouri |
| 1990 | BA | Saint Louis University |
My scientific interest is in thoracic oncology, more specifically the study and management of all forms of lung cancer. The Thoracic Oncology Program is involved in many studies in various aspects of lung cancer research including areas of epidermal growth factor receptor inhibition, anti-angiogenesis, cell-cycle inhibitors, and novel chemotherapeutic agents. In addition, the Thoracic Oncology Program is sponsoring basic science research as it pertains to lung cancer.
Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ Cell Tumors: A Hoosier Cancer Research Network Study GU14-206.
Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Oct 17
Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Oct 17
Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS; Clinical genitourinary cancer 2017 Oct 16
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS; Clinical genitourinary cancer 2017 Oct 16
Multidisciplinary Clinic Approach Improves Overall Survival Outcomes of Patients with Metastatic Germ Cell Tumors.
Albany C; Adra N; Snavely AC; Cary C; Masterson TA; Foster RS; Kesler K; Ulbright TM; Cheng L; Chovanec M; Taza F; Ku K; Brames MJ; Hanna NH; Einhorn LH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov 10
Albany C; Adra N; Snavely AC; Cary C; Masterson TA; Foster RS; Kesler K; Ulbright TM; Cheng L; Chovanec M; Taza F; Ku K; Brames MJ; Hanna NH; Einhorn LH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov 10
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.
Harari SE; Sassoon DJ; Priemer DS; Jacob JM; Eble JN; Caliò A; Grignon DJ; Idrees M; Albany C; Masterson TA; Hanna NH; Foster RS; Ulbright TM; Einhorn LH; Cheng L; Urologic oncology 2017 Jun 21
Harari SE; Sassoon DJ; Priemer DS; Jacob JM; Eble JN; Caliò A; Grignon DJ; Idrees M; Albany C; Masterson TA; Hanna NH; Foster RS; Ulbright TM; Einhorn LH; Cheng L; Urologic oncology 2017 Jun 21
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.
Lesaffre E; Edelman MJ; Hanna NH; Park K; Thatcher N; Willemsen S; Gaschler-Markefski B; Kaiser R; Manegold C; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jul 1
Lesaffre E; Edelman MJ; Hanna NH; Park K; Thatcher N; Willemsen S; Gaschler-Markefski B; Kaiser R; Manegold C; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jul 1
TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer.
Adra N; Cheng L; Hanna NH; Durm G; Clinical genitourinary cancer 2017 Feb 1
Adra N; Cheng L; Hanna NH; Durm G; Clinical genitourinary cancer 2017 Feb 1
Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.
Tandstad T; Kollmannsberger CK; Roth BJ; Jeldres C; Gillessen S; Fizazi K; Daneshmand S; Lowrance WT; Hanna NH; Albany C; Foster R; Cedermark GC; Feldman DR; Powles T; Lewis MA; Grimison PS; Bank D; Porter C; Albers P; De Santis M; Srinivas S; Bosl GJ; Nichols CR; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Aug 30
Tandstad T; Kollmannsberger CK; Roth BJ; Jeldres C; Gillessen S; Fizazi K; Daneshmand S; Lowrance WT; Hanna NH; Albany C; Foster R; Cedermark GC; Feldman DR; Powles T; Lewis MA; Grimison PS; Bank D; Porter C; Albers P; De Santis M; Srinivas S; Bosl GJ; Nichols CR; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Aug 30
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer.
Gaschler-Markefski B; Sikken P; Heymach JV; Gottfried M; Mellemgaard A; Novello S; Gann CN; Barrueco J; Reck M; Hanna NH; Kaiser R; ESMO open 2017 Apr 11
Gaschler-Markefski B; Sikken P; Heymach JV; Gottfried M; Mellemgaard A; Novello S; Gann CN; Barrueco J; Reck M; Hanna NH; Kaiser R; ESMO open 2017 Apr 11
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.
Hanna NH; Kaiser R; Sullivan RN; Aren OR; Ahn MJ; Tiangco B; Voccia I; Pawel JV; Kovcin V; Agulnik J; Gaschler-Markefski B; Barrueco J; Sikken P; Schloss C; Kim JH; LUME-Lung 2 Study group.; Lung cancer (Amsterdam, Netherlands) 2016 Oct 27
Hanna NH; Kaiser R; Sullivan RN; Aren OR; Ahn MJ; Tiangco B; Voccia I; Pawel JV; Kovcin V; Agulnik J; Gaschler-Markefski B; Barrueco J; Sikken P; Schloss C; Kim JH; LUME-Lung 2 Study group.; Lung cancer (Amsterdam, Netherlands) 2016 Oct 27
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Nov 21
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Nov 21
Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C; Annals of oncology : official journal of the European Society for Medical Oncology 2016 Feb 9
Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C; Annals of oncology : official journal of the European Society for Medical Oncology 2016 Feb 9
Phase II study of fosaprepitant?+?5HT3 receptor antagonist?+?dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Adra N; Albany C; Brames MJ; Case-Eads S; Johnson CS; Liu Z; Fausel CA; Breen T; Hanna NH; Hauke RJ; Picus J; Einhorn LH; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016 Feb 2
Adra N; Albany C; Brames MJ; Case-Eads S; Johnson CS; Liu Z; Fausel CA; Breen T; Hanna NH; Hauke RJ; Picus J; Einhorn LH; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016 Feb 2
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C; Clinical genitourinary cancer 2016 Aug 8
Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C; Clinical genitourinary cancer 2016 Aug 8
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced nonsmall cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
Hanna NH; Dahlberg SE; Kolesar JM; Aggarwal C; Hirsch FR; Ramalingam SS; Schiller JH; Cancer 2015 Mar 4
Hanna NH; Dahlberg SE; Kolesar JM; Aggarwal C; Hirsch FR; Ramalingam SS; Schiller JH; Cancer 2015 Mar 4
Electronic nicotine delivery systems: a policy statement from the american association for cancer research and the american society of clinical oncology.
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW; Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jan 8
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW; Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jan 8
Electronic Nicotine Delivery Systems: A Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology.
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Jan 8
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Jan 8
Dimensional versus categorical use of the PHQ-9 depression scale among persons with non-small-cell lung cancer: a pilot study including quality-of-life comparisons.
Whitney KA; Steiner AR; Lysaker PH; Estes DD; Hanna NH; The journal of supportive oncology 2010 Sep
Whitney KA; Steiner AR; Lysaker PH; Estes DD; Hanna NH; The journal of supportive oncology 2010 Sep
Advanced non-small cell lung cancer: the role of maintenance therapy.
Agarwala AK; Hanna NH; Therapeutic advances in medical oncology 2010 Jan
Agarwala AK; Hanna NH; Therapeutic advances in medical oncology 2010 Jan
The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
Jalal SI; Ademuyiwa FO; Hanna NH; Current opinion in oncology 2009 Mar
Jalal SI; Ademuyiwa FO; Hanna NH; Current opinion in oncology 2009 Mar
Is"chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer.
Whitney KA; Lysaker PH; Steiner AR; Hook JN; Estes DD; Hanna NH; The journal of supportive oncology 2008 Sep
Whitney KA; Lysaker PH; Steiner AR; Hook JN; Estes DD; Hanna NH; The journal of supportive oncology 2008 Sep
Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH; Clinical lung cancer 2007 Sep
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH; Clinical lung cancer 2007 Sep
Salvage therapy in patients with advanced non-small cell lung cancer.
Bedano PM; Hanna NH; Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006 Jul
Bedano PM; Hanna NH; Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006 Jul
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial.
Moore AM; Einhorn LH; Estes D; Govindan R; Axelson J; Vinson J; Breen TE; Yu M; Hanna NH; Lung cancer (Amsterdam, Netherlands) 2006 Feb 20
Moore AM; Einhorn LH; Estes D; Govindan R; Axelson J; Vinson J; Breen TE; Yu M; Hanna NH; Lung cancer (Amsterdam, Netherlands) 2006 Feb 20
Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
Bernstein ED; Herbert SM; Hanna NH; Annals of surgical oncology 2006 Feb 1
Bernstein ED; Herbert SM; Hanna NH; Annals of surgical oncology 2006 Feb 1
Long-term survival in a patient with stage IV non-small-cell lung carcinoma after bone metastasectomy.
Agarwala AK; Hanna NH; Clinical lung cancer 2005 May
Agarwala AK; Hanna NH; Clinical lung cancer 2005 May
American Board of Internal Medicine - Internal Medicine
Lung cancer, esophageal cancer
Org:
Desc: Inspirational Educator Award
Scope: School
Date: 2019-09-01
Desc: Inspirational Educator Award
Scope: School
Date: 2019-09-01
Org:
Desc: Trustee Teaching Award
Scope: University
Date: 2012-05-01
Desc: Trustee Teaching Award
Scope: University
Date: 2012-05-01
Org:
Desc: Trustee Teaching Award
Scope: University
Date: 2009-05-01
Desc: Trustee Teaching Award
Scope: University
Date: 2009-05-01
Org: MD Anderson Cancer Center/Baylor College of Medicine Hematology and Medical Oncology Board Review
Desc: Charles A. Koller, MD, Memorial Lectureship recipient
Scope: University
Date: 1905-07-15
Desc: Charles A. Koller, MD, Memorial Lectureship recipient
Scope: University
Date: 1905-07-15
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.